{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:28:37Z","timestamp":1792578517178,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03168-7","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T19:16:50Z","timestamp":1750965410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Phospholipid Complex-based Topical Gel for Codelivery of Erlotinib and Methotrexate in Psoriasis"],"prefix":"10.1208","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0688-9563","authenticated-orcid":false,"given":"Sanyog","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Mali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junia","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chander Parkash","family":"Dora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul R.","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"3168_CR1","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","volume":"157","author":"AW Armstrong","year":"2021","unstructured":"Armstrong AW, Mehta MD, Schupp CW, Gondo GC, Bell SJ, Griffiths CEM. Psoriasis Prevalence in Adults in the United States. JAMA Dermatol. 2021;157:940\u20136.","journal-title":"JAMA Dermatol"},{"key":"3168_CR2","doi-asserted-by":"publisher","first-page":"m1590","DOI":"10.1136\/bmj.m1590","volume":"369","author":"R Parisi","year":"2020","unstructured":"Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369:m1590.","journal-title":"BMJ"},{"key":"3168_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jdds.2015.07.004","volume":"20","author":"SR Feldman","year":"2016","unstructured":"Feldman SR, Mathias SD, Schenkel B, Colwell HH, McQuarrie K, Randazzo B, et al. Development of a patient-reported outcome questionnaire for use in adults with moderate-to-severe plaque psoriasis: The Psoriasis Symptoms and Signs Diary. J Dermatol Dermatol Surg. 2016;20:19\u201326.","journal-title":"J Dermatol Dermatol Surg"},{"key":"3168_CR4","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.ijbiomac.2018.08.136","volume":"120","author":"P Tripathi","year":"2018","unstructured":"Tripathi P, Kumar A, Jain PK, Patel JR. Carbomer gel bearing methotrexate loaded lipid nanocontainers shows improved topical delivery intended for effective management of psoriasis. Int J Biol Macromol. 2018;120:1322\u201334.","journal-title":"Int J Biol Macromol"},{"key":"3168_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/0019-5154.48977","volume":"54","author":"RP Das","year":"2009","unstructured":"Das RP, Jain AK, Ramesh V. CURRENT CONCEPTS IN THE PATHOGENESIS OF PSORIASIS. Indian J Dermatol. 2009;54:7\u201312.","journal-title":"Indian J Dermatol"},{"key":"3168_CR6","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","volume":"128","author":"MA Lowes","year":"2008","unstructured":"Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS, et al. Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells. J Investig Dermatol. 2008;128:1207\u201311.","journal-title":"J Investig Dermatol"},{"key":"3168_CR7","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature05505","volume":"445","author":"Y Zheng","year":"2007","unstructured":"Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, et al. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 2007;445:648\u201351.","journal-title":"Nature"},{"key":"3168_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4103\/2229-5178.209622","volume":"8","author":"R Torsekar","year":"2017","unstructured":"Torsekar R, Gautam MM. Topical Therapies in Psoriasis. Indian Dermatol Online J. 2017;8:235.","journal-title":"Indian Dermatol Online J"},{"key":"3168_CR9","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2147\/IJN.S443812","volume":"19","author":"SF Elhabal","year":"2024","unstructured":"Elhabal SF, Abdelaal N, Al-Zuhairy SA, Elrefai MFM, Khalifa MM, Khasawneh MA, et al. Revolutionizing Psoriasis Topical Treatment: Enhanced Efficacy Through Ceramide\/Phospholipid Composite Cerosomes Co-Delivery of Cyclosporine and Dithranol: In-Vitro, Ex-Vivo, and in-Vivo Studies. IJN. 2024;19:1163\u201387.","journal-title":"IJN"},{"key":"3168_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.colsurfb.2016.01.021","volume":"141","author":"H Bessar","year":"2016","unstructured":"Bessar H, Venditti I, Benassi L, Vaschieri C, Azzoni P, Pellacani G, et al. Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis. Colloids Surf, B. 2016;141:141\u20137.","journal-title":"Colloids Surf, B"},{"key":"3168_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.colsurfb.2017.07.080","volume":"159","author":"M Ferreira","year":"2017","unstructured":"Ferreira M, Barreiros L, Segundo MA, Torres T, Selores M, Costa Lima SA, et al. Topical co-delivery of methotrexate and etanercept using lipid nanoparticles: A targeted approach for psoriasis management. Colloids Surf, B. 2017;159:23\u20139.","journal-title":"Colloids Surf, B"},{"key":"3168_CR12","doi-asserted-by":"publisher","first-page":"e0153740","DOI":"10.1371\/journal.pone.0153740","volume":"11","author":"J West","year":"2016","unstructured":"West J, Ogston S, Foerster J. Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials. PLoS ONE. 2016;11:e0153740.","journal-title":"PLoS ONE"},{"key":"3168_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrd1607","volume":"4","author":"AB Gottlieb","year":"2005","unstructured":"Gottlieb AB. Psoriasis: emerging therapeutic strategies. Nat Rev Drug Discov. 2005;4:19\u201334.","journal-title":"Nat Rev Drug Discov"},{"key":"3168_CR14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1001\/archderm.1971.04000210010003","volume":"104","author":"GD Weinstein","year":"1971","unstructured":"Weinstein GD, Goldfaden G, Frost P. Methotrexate: Mechanism of Action on DNA Synthesis in Psoriasis. Arch Dermatol. 1971;104:236\u201343.","journal-title":"Arch Dermatol"},{"key":"3168_CR15","first-page":"S19","volume":"15","author":"A Martin","year":"2022","unstructured":"Martin A, Thatiparthi A, Liu J, Wu JJ. Interleukin-17 Inhibitor Combination Therapies for the Treatment of Psoriasis: A Systematic Review. J Clin Aesthet Dermatol. 2022;15:S19-31.","journal-title":"J Clin Aesthet Dermatol"},{"key":"3168_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1634\/theoncologist.10-7-461","volume":"10","author":"MH Cohen","year":"2005","unstructured":"Cohen MH, Johnson JR, Chen Y-F, Sridhara R, Pazdur R. FDA Drug Approval Summary: Erlotinib (Tarceva\u00ae) Tablets. Oncologist. 2005;10:461\u20136.","journal-title":"Oncologist"},{"key":"3168_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2133.2004.06304.x","volume":"152","author":"C Johansen","year":"2005","unstructured":"Johansen C, Kragballe K, Westergaard M, Henningsen J, Kristiansen K, Iversen L. The mitogen-activated protein kinases p38 and ERK1\/2 are increased in lesional psoriatic skin. Br J Dermatol. 2005;152:37\u201342.","journal-title":"Br J Dermatol"},{"key":"3168_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jconrel.2016.05.017","volume":"246","author":"CHA Boakye","year":"2017","unstructured":"Boakye CHA, Patel K, Doddapaneni R, Bagde A, Marepally S, Singh M. Novel amphiphilic lipid augments the co-delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment. J Control Release. 2017;246:120\u201332.","journal-title":"J Control Release"},{"key":"3168_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12026-014-8564-6","volume":"60","author":"VC Rom\u00e3o","year":"2014","unstructured":"Rom\u00e3o VC, Lima A, Bernardes M, Canh\u00e3o H, Fonseca JE. Three decades of low-dose methotrexate in rheumatoid arthritis: Can we predict toxicity? Immunol Res. 2014;60:289\u2013310.","journal-title":"Immunol Res"},{"key":"3168_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000069773","volume":"49","author":"S Vezmar","year":"2003","unstructured":"Vezmar S, Becker A, Bode U, Jaehde U. Biochemical and clinical aspects of methotrexate neurotoxicity. Chemother. 2003;49:92\u2013104.","journal-title":"Chemother"},{"key":"3168_CR21","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/sj.bjc.6604353","volume":"98","author":"NF Smith","year":"2008","unstructured":"Smith NF, Baker SD, Gonzalez FJ, Harris JW, Figg WD, Sparreboom A. Modulation of erlotinib pharmacokinetics in mice by a novel cytochrome P450 3A4 inhibitor, BAS 100. Br J Cancer. 2008;98:1630\u20132.","journal-title":"Br J Cancer"},{"key":"3168_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0378-5173(00)00378-1","volume":"199","author":"V Jenning","year":"2000","unstructured":"Jenning V, Th\u00fcnemann AF, Gohla SH. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm. 2000;199:167\u201377.","journal-title":"Int J Pharm"},{"key":"3168_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4103\/0378-6323.193614","volume":"83","author":"AK Bubna","year":"2017","unstructured":"Bubna AK. Iontophoresis with topical 0.05% tretinoin for the management of recalcitrant palmar psoriasis: A report of two cases. Indian J Dermatol Venereol Leprol. 2017;83:119\u201321.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"3168_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijpharm.2016.08.008","volume":"512","author":"M Ferreira","year":"2016","unstructured":"Ferreira M, Silva E, Barreiros L, Segundo MA, Costa Lima SA, Reis S. Methotrexate loaded lipid nanoparticles for topical management of skin-related diseases: Design, characterization and skin permeation potential. Int J Pharm. 2016;512:14\u201321.","journal-title":"Int J Pharm"},{"key":"3168_CR25","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1080\/17425247.2021.2011857","volume":"18","author":"O Katari","year":"2021","unstructured":"Katari O, Jain S. Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics for the treatment of psoriasis. Expert Opin Drug Deliv. 2021;18:1857\u201372.","journal-title":"Expert Opin Drug Deliv"},{"key":"3168_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jddst.2018.12.020","volume":"49","author":"P Rajitha","year":"2019","unstructured":"Rajitha P, Shammika P, Aiswarya S, Gopikrishnan A, Jayakumar R, Sabitha M. Chaulmoogra oil based methotrexate loaded topical nanoemulsion for the treatment of psoriasis. J Drug Deliv Sci Technol. 2019;49:463\u201376.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3168_CR27","doi-asserted-by":"publisher","first-page":"114901","DOI":"10.1016\/j.addr.2023.114901","volume":"199","author":"R Sharma","year":"2023","unstructured":"Sharma R, Yadav S, Yadav V, Akhtar J, Katari O, Kuche K, et al. Recent advances in lipid-based long-acting injectable depot formulations. Adv Drug Deliv Rev. 2023;199:114901.","journal-title":"Adv Drug Deliv Rev"},{"key":"3168_CR28","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.2147\/IJN.S109565","volume":"11","author":"A Zeb","year":"2016","unstructured":"Zeb A, Qureshi OS, Kim H-S, Cha J-H, Kim H-S, Kim J-K. Improved skin permeation of methotrexate via nanosized ultradeformable liposomes. Int J Nanomedicine. 2016;11:3813\u201324.","journal-title":"Int J Nanomedicine"},{"key":"3168_CR29","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s11095-010-0130-x","volume":"27","author":"G Fricker","year":"2010","unstructured":"Fricker G, Kromp T, Wendel A, Blume A, Zirkel J, Rebmann H, et al. Phospholipids and lipid-based formulations in oral drug delivery. Pharm Res. 2010;27:1469\u201386.","journal-title":"Pharm Res"},{"key":"3168_CR30","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1023\/A:1018998529283","volume":"11","author":"KD Peck","year":"1994","unstructured":"Peck KD, Ghanem A-H, Higuchi WI. Hindered Diffusion of Polar Molecules Through and Effective Pore Radii Estimates of Intact and Ethanol Treated Human Epidermal Membrane. Pharm Res. 1994;11:1306\u201314.","journal-title":"Pharm Res"},{"key":"3168_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijpharm.2017.07.060","volume":"530","author":"CP Dora","year":"2017","unstructured":"Dora CP, Kushwah V, Katiyar SS, Kumar P, Pillay V, Suresh S, et al. Improved metabolic stability and therapeutic efficacy of a novel molecular gemcitabine phospholipid complex. Int J Pharm. 2017;530:113\u201327.","journal-title":"Int J Pharm"},{"key":"3168_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.09.071","volume":"534","author":"CP Dora","year":"2017","unstructured":"Dora CP, Kushwah V, Katiyar SS, Kumar P, Pillay V, Suresh S, et al. Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid. Int J Pharm. 2017;534:1\u201313.","journal-title":"Int J Pharm"},{"key":"3168_CR33","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3109\/10837450.2015.1026605","volume":"21","author":"V Avasatthi","year":"2016","unstructured":"Avasatthi V, Pawar H, Dora CP, Bansod P, Gill MS, Suresh S. A novel nanogel formulation of methotrexate for topical treatment of psoriasis: optimization, in vitro and in vivo evaluation. Pharm Dev Technol. 2016;21:554\u201362.","journal-title":"Pharm Dev Technol"},{"key":"3168_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijpharm.2007.05.061","volume":"345","author":"KA Shah","year":"2007","unstructured":"Shah KA, Date AA, Joshi MD, Patravale VB. Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery. Int J Pharm. 2007;345:163\u201371.","journal-title":"Int J Pharm"},{"key":"3168_CR35","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1517\/17425247.2014.938634","volume":"11","author":"R Sonawane","year":"2014","unstructured":"Sonawane R, Harde H, Katariya M, Agrawal S, Jain S. Solid lipid nanoparticles-loaded topical gel containing combination drugs: an approach to offset psoriasis. Expert Opin Drug Deliv. 2014;11:1833\u201347.","journal-title":"Expert Opin Drug Deliv"},{"key":"3168_CR36","doi-asserted-by":"publisher","first-page":"124026","DOI":"10.1016\/j.ijpharm.2024.124026","volume":"655","author":"A Sontakke","year":"2024","unstructured":"Sontakke A, Dighe S, Sharma R, Yadav V, Jain S. Harnessing the potential of fatty Acid-Surfactant-Based micellar gel for enhanced topical delivery of Apremilast in psoriasis treatment. Int J Pharm. 2024;655:124026.","journal-title":"Int J Pharm"},{"key":"3168_CR37","doi-asserted-by":"publisher","first-page":"104214","DOI":"10.1016\/j.drudis.2024.104214","volume":"29","author":"A Sitovs","year":"2024","unstructured":"Sitovs A, Mohylyuk V. Ex vivo permeability study of poorly soluble drugs across gastrointestinal membranes: acceptor compartment media composition. Drug Discovery Today. 2024;29:104214.","journal-title":"Drug Discovery Today"},{"key":"3168_CR38","doi-asserted-by":"publisher","first-page":"104435","DOI":"10.1016\/j.jddst.2023.104435","volume":"84","author":"S Jain","year":"2023","unstructured":"Jain S, Pattewad V, Bhargavi N, Yadav S, Sharma R, Ghadi R, et al. Exploring the therapeutic potential of functional excipient-based nanoemulgel of fluticasone propionate for the management of psoriasis. J Drug Deliv Sci Technol. 2023;84:104435.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3168_CR39","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/jps.2600840920","volume":"84","author":"VP Shah","year":"1995","unstructured":"Shah VP, Elkins JS. In-vitro release from corticosteroid ointments. J Pharm Sci. 1995;84:1139\u201340.","journal-title":"J Pharm Sci"},{"key":"3168_CR40","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0168-3659(00)00309-6","volume":"69","author":"B Baroli","year":"2000","unstructured":"Baroli B, L\u00f3pez-Quintela MA, Delgado-Charro MB, Fadda AM, Blanco-M\u00e9ndez J. Microemulsions for topical delivery of 8-methoxsalen. J Control Release. 2000;69:209\u201318.","journal-title":"J Control Release"},{"key":"3168_CR41","doi-asserted-by":"crossref","unstructured":"Jain S, Mittal A, Jain AK. Enhanced topical delivery of cyclosporin-A using PLGA nanoparticles as carrier. Curr Nanosci. 2011;7:524\u201330.","DOI":"10.2174\/157341311796196835"},{"key":"3168_CR42","doi-asserted-by":"publisher","first-page":"43917","DOI":"10.1039\/C5RA06047H","volume":"5","author":"H Harde","year":"2015","unstructured":"Harde H, Agrawal AK, Katariya M, Kale D, Jain S. Development of a topical adapalene-solid lipid nanoparticle loaded gel with enhanced efficacy and improved skin tolerability. RSC Adv. 2015;5:43917\u201329.","journal-title":"RSC Adv"},{"key":"3168_CR43","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2217\/nnm-2018-0002","volume":"13","author":"S Jain","year":"2018","unstructured":"Jain S, Kale DP, Swami R, Katiyar SS. Codelivery of benzoyl peroxide & adapalene using modified liposomal gel for improved acne therapy. Nanomed (Lond). 2018;13:1481\u201393.","journal-title":"Nanomed (Lond)"},{"key":"3168_CR44","first-page":"2251","volume":"13","author":"A Jain","year":"2017","unstructured":"Jain A, Pooladanda V, Bulbake U, Doppalapudi S, Rafeeqi TA, Godugu C, et al. Liposphere mediated topical delivery of thymoquinone in the treatment of psoriasis. Nanomedicine: Nanotechnology. Biol Med. 2017;13:2251\u201362.","journal-title":"Biol Med"},{"key":"3168_CR45","doi-asserted-by":"publisher","first-page":"e67078","DOI":"10.1371\/journal.pone.0067078","volume":"8","author":"J Sun","year":"2013","unstructured":"Sun J, Zhao Y, Hu J. Curcumin Inhibits Imiquimod-Induced Psoriasis-Like Inflammation by Inhibiting IL-1beta and IL-6 Production in Mice. PLoS ONE. 2013;8:e67078.","journal-title":"PLoS ONE"},{"key":"3168_CR46","doi-asserted-by":"crossref","unstructured":"Singh D, Rawat MSM, Semalty A, Semalty M. Gallic acid-phospholipid complex: drug incorporation and physicochemical characterization. Lett Drug Des Discovery. 2011;8:284\u201391.","DOI":"10.2174\/157018011794578240"},{"key":"3168_CR47","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1021\/acs.molpharmaceut.1c00141","volume":"18","author":"SD Thakore","year":"2021","unstructured":"Thakore SD, Akhtar J, Jain R, Paudel A, Bansal AK. Analytical and Computational Methods for the Determination of Drug-Polymer Solubility and Miscibility. Mol Pharm. 2021;18:2835\u201366.","journal-title":"Mol Pharm"},{"key":"3168_CR48","doi-asserted-by":"publisher","first-page":"62989","DOI":"10.1039\/C5RA12459J","volume":"5","author":"NK Garg","year":"2015","unstructured":"Garg NK, Singh B, Sharma G, Kushwah V, Tyagi RK, Jain S, et al. Development and characterization of single step self-assembled lipid polymer hybrid nanoparticles for effective delivery of methotrexate. RSC Adv. 2015;5:62989\u201399.","journal-title":"RSC Adv"},{"key":"3168_CR49","doi-asserted-by":"publisher","first-page":"86717","DOI":"10.1039\/C6RA17260A","volume":"6","author":"Y Li","year":"2016","unstructured":"Li Y, Lin J, Liu G, Li Y, Song L, Fan Z, et al. Self-assembly of multifunctional integrated nanoparticles loaded with a methotrexate\u2013phospholipid complex: combining simplicity and efficacy in both targeting and anticancer effects. RSC Adv. 2016;6:86717\u201327.","journal-title":"RSC Adv"},{"key":"3168_CR50","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.carbpol.2015.10.080","volume":"137","author":"CP Dora","year":"2016","unstructured":"Dora CP, Trotta F, Kushwah V, Devasari N, Singh C, Suresh S, et al. Potential of erlotinib cyclodextrin nanosponge complex to enhance solubility, dissolution rate, in vitro cytotoxicity and oral bioavailability. Carbohyd Polym. 2016;137:339\u201349.","journal-title":"Carbohyd Polym"},{"key":"3168_CR51","doi-asserted-by":"publisher","first-page":"105825","DOI":"10.1016\/j.jddst.2024.105825","volume":"97","author":"Yasmeen","year":"2024","unstructured":"Yasmeen, Khan MA, Iqbal Z, Aqil M. Carbopol 934-based transethosomal gel of Glycyrrhizic acid for the management of skin cancer. J Drug Deliv Sci Technol. 2024;97:105825.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3168_CR52","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.addr.2006.09.004","volume":"58","author":"C-C Lin","year":"2006","unstructured":"Lin C-C, Metters AT. Hydrogels in controlled release formulations: Network design and mathematical modeling. Adv Drug Deliv Rev. 2006;58:1379\u2013408.","journal-title":"Adv Drug Deliv Rev"},{"key":"3168_CR53","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/ics.12302","volume":"38","author":"M Estanqueiro","year":"2016","unstructured":"Estanqueiro M, Amaral MH, Sousa Lobo JM. Comparison between sensory and instrumental characterization of topical formulations: impact of thickening agents. Int J Cosmet Sci. 2016;38:389\u201398.","journal-title":"Int J Cosmet Sci"},{"key":"3168_CR54","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ejpb.2010.02.011","volume":"75","author":"T Gratieri","year":"2010","unstructured":"Gratieri T, Gelfuso GM, Rocha EM, Sarmento VH, de Freitas O, Lopez RFV. A poloxamer\/chitosan in situ forming gel with prolonged retention time for ocular delivery. Eur J Pharm Biopharm. 2010;75:186\u201393.","journal-title":"Eur J Pharm Biopharm"},{"key":"3168_CR55","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1021\/mp500254j","volume":"11","author":"Y Li","year":"2014","unstructured":"Li Y, Wu H, Yang X, Jia M, Li Y, Huang Y, et al. Mitomycin C-Soybean Phosphatidylcholine Complex-Loaded Self-Assembled PEG-Lipid-PLA Hybrid Nanoparticles for Targeted Drug Delivery and Dual-Controlled Drug Release. Mol Pharmaceutics. 2014;11:2915\u201327.","journal-title":"Mol Pharmaceutics"},{"key":"3168_CR56","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3109\/10717544.2014.923067","volume":"23","author":"P Negi","year":"2016","unstructured":"Negi P, Singh B, Sharma G, Beg S, Raza K, Katare OP. Phospholipid microemulsion-based hydrogel for enhanced topical delivery of lidocaine and prilocaine: QbD-based development and evaluation. Drug Delivery. 2016;23:941\u201357.","journal-title":"Drug Delivery"},{"key":"3168_CR57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4155\/tde-2021-0059","volume":"13","author":"A Bisht","year":"2022","unstructured":"Bisht A, Hemrajani C, Upadhyay N, Nidhi P, Rolta R, Rathore C, et al. Azelaic Acid and Melaleuca Alternifolia Essential Oil co-loaded Vesicular Carrier for Combinational Therapy of Acne. Ther Deliv. 2022;13:13\u201329.","journal-title":"Ther Deliv"},{"key":"3168_CR58","doi-asserted-by":"publisher","first-page":"35","DOI":"10.15171\/apb.2017.005","volume":"7","author":"K Gnananath","year":"2017","unstructured":"Gnananath K, Nataraj KS, Rao BG. Phospholipid complex technique for superior bioavailability of phytoconstituents. Adv Pharm Bull. 2017;7:35.","journal-title":"Adv Pharm Bull"},{"key":"3168_CR59","first-page":"1121","volume":"10","author":"SA Rashid","year":"2021","unstructured":"Rashid SA, Bashir S, Naseem F, Farid A, Rather IA, Hakeem KR. Olive Oil Based Methotrexate Loaded Topical Nanoemulsion Gel for the Treatment of Imiquimod Induced Psoriasis-like Skin Inflammation in an Animal Model. Biol (Basel). 2021;10:1121.","journal-title":"Biol (Basel)"},{"key":"3168_CR60","doi-asserted-by":"publisher","first-page":"6892","DOI":"10.3748\/wjg.v21.i22.6892","volume":"21","author":"N Balato","year":"2015","unstructured":"Balato N, Napolitano M, Ayala F, Patruno C, Megna M, Tarantino G. Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation. World J Gastroenterol: WJG. 2015;21:6892.","journal-title":"World J Gastroenterol: WJG"},{"key":"3168_CR61","doi-asserted-by":"publisher","first-page":"133956","DOI":"10.1016\/j.cej.2021.133956","volume":"431","author":"X Jiang","year":"2022","unstructured":"Jiang X, Yao Q, Xia X, Tang Y, Sun M, Li Y, et al. Self-assembled nanoparticles with bilirubin\/JPH203 alleviate imiquimod-induced psoriasis by reducing oxidative stress and suppressing Th17 expansion. Chem Eng J. 2022;431:133956.","journal-title":"Chem Eng J"},{"key":"3168_CR62","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon A, Sch\u00e4kel K. Psoriasis Pathogenesis and Treatment. Int J Mol Sci. 2019;20:1475.","journal-title":"Int J Mol Sci"},{"key":"3168_CR63","doi-asserted-by":"crossref","unstructured":"Kalita B, Patwary BN. Formulation and in vitro evaluation of hesperidin-phospholipid complex and its antioxidant potential. Curr Drug Ther. 2020;15:28\u201336.","DOI":"10.2174\/1574885514666190226155933"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03168-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03168-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03168-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T23:33:48Z","timestamp":1757201628000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03168-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":63,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["3168"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03168-7","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"assertion":[{"value":"23 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"172"}}